Summary
CVS Health Corporation (CVS) filed an 8-K on May 25, 2023, to retroactively revise sections of its 2022 Annual Report on Form 10-K. These revisions are primarily to reflect a previously announced realignment of its business segments, effective Q1 2023, into four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other. This new structure aims to better align with the company's operating model and how its Chief Operating Decision Maker reviews performance. The filing also details adjustments related to the exclusion of net realized capital gains or losses from adjusted operating income, additional disclosures on the impact of declining Medicare Advantage members with high star ratings, and the adoption of a new accounting standard for long-duration insurance contracts. Investors should note that these changes are retrospective and have been applied to prior periods, including the Q1 2023 Form 10-Q, and are now being incorporated into the 2022 Form 10-K for completeness and consistency across SEC filings.
Key Highlights
- 1CVS Health is retroactively revising its 2022 Form 10-K to reflect its Q1 2023 segment realignment.
- 2The company has reorganized into four reportable segments: Health Care Benefits, Health Services, Pharmacy & Consumer Wellness, and Corporate/Other.
- 3Revisions update business descriptions, management's discussion and analysis, market risk disclosures, and financial statements.
- 4Net realized capital gains/losses will be excluded from adjusted operating income going forward.
- 5Additional disclosures regarding the impact of declining Medicare Advantage members with high star ratings are included.
- 6The company has adopted a new accounting standard for long-duration insurance contracts, effective January 1, 2023.